Cell-Free DNA Liquid Biopsies for Precision Cardiovascular Medicine
Fördersumme: € 999.285
Personalized risk assessment for embryonal tumor predisposition
Fördersumme: € 999.003
Uncovering the Genetic Contribution of Human Endogenous Retroviruses to ME/CFS
Fördersumme: € 39.504
MEndelian Randomisation for Evaluating Medicines and Approved Pharmacotherapies in ME/CFS
Fördersumme: € 37.884
Persistent Platelet-Monocyte CrossTalk Underlies Failure to Resolve Inflammation and Symptoms in ME/CFS
Fördersumme: € 35.860
Engineering enhanced microbiome function using synthetic ecology
Dauer: 48 Monate, Fördersumme: € 897.156